HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CEP regimen

chemotherapy protocol consisting of the above cpds; used in treatment of patients with advanced non-small-cell lung cancer

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CEP regimen: 2
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CEP regimen: 2
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CEP regimen: 2
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        Epirubicin: 3820
        CEP regimen: 2
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        Epirubicin: 3820
        CEP regimen: 2

Related Diseases

1.	Hodgkin Disease (Hodgkin's Disease) 12/31/1994 - "CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease."
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/01/1997 - "However, there were 2 CR and 71 PR in 161 patients with non-small cell lung cancer treated by CEP regimen (CTX, EPI and cisplatin PDD), with a response rate of 45.3%. "

Related Drugs and Biologics

1.	Prednimustine
2.	Lomustine (CCNU)
3.	Etoposide (VP 16)
4.	Cisplatin (Platino)